Other studies observed increased levels of CTGF associated to the development of proteinuria and interstitial fibrosis in murine models of diabetic nephropathy; in these studies, administration of CTGF antisense reduced proteinuria and serum creatinine and mesangial expansion [34]. The gene discussed is CCN2; the disease is diabetic kidney disease.